Feasibility and acceptability of brief behavioral therapy for cancer-related insomnia: effects on insomnia and circadian rhythm during chemotherapy: a phase II randomised multicentre controlled trial-Reference-Cited by-同舟云学术

Feasibility and acceptability of brief behavioral therapy for cancer-related insomnia: effects on insomnia and circadian rhythm during chemotherapy: a phase II randomised multicentre controlled trial

Published:2018-07-20 Issue:3 Volume:119 Page:274-281
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Palesh Oxana,Scheiber Caroline,Kesler Shelli,Janelsins Michelle C.,Guido Joseph J.,Heckler Charles,Cases Mallory G.,Miller Jessica,Chrysson Nick G.,Mustian Karen M.

Funder

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s41416-018-0154-2.pdf

Reference41 articles.

1. Palesh, O. et al. Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J. Clin. Oncol. 28, 292–298 (2010).

2. Davidson, J. R., MacLean, A. W., Brundage, M. D. & Schulze, K. Sleep disturbance in cancer patients. Soc. Sci. Med. 54, 1309–1321 (2002).

3. Savard, J. & Morin, C. M. Insomnia in the context of cancer: a review of a neglected problem. J. Clin. Oncol. 19, 895–908 (2001).